The Global Peripheral Vascular Devices Market Size is projected to grow at a CAGR of 5.92% during the forecast period from 2025 to 2032 | DelveInsight

The Peripheral Vascular Devices market is estimated at USD 9,853.30 million in 2024 and is projected to reach USD 15,544.32 million by 2032. Growth is anchored in the rising burden of Peripheral Artery Disease (PAD) and vascular disorders, increasing preference for minimally invasive procedures, and continuous technological advancement in product design.

DelveInsight's Peripheral Vascular Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Peripheral Vascular Devices companies' market shares, challenges, Peripheral Vascular Devices Market Drivers, barriers, trends, and key market Peripheral Vascular Devices companies in the market.

To read more about the latest highlights related to the Peripheral Vascular Devices Market @ https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Key Takeaways from the Peripheral Vascular Devices Market Report

- In February 2025, Stryker completed the acquisition of Inari Medical, Inc., significantly strengthening its position in the thrombectomy market. Strategic significance: Adds Inari's FlowTriever® and ClotTriever® systems, complementary to Stryker's existing Neurovascular business.
- In June 2025, InspireMD's CGuard® Prime Embolic Prevention System (EPS) received CE Mark approval under the European Medical Device Regulation (MDR) for use in stroke prevention. Strategic significance: Expands access to embolic protection technology across the European market.
- In May 2025, Terumo Interventional Systems announced early U.S. commercial availability of its FDA-approved ROADSAVERTM Carotid Stent System. Strategic significance: Broadens the U.S. carotid stenting portfolio for use with embolic protection systems.
- The global Peripheral Vascular Devices market is growing at a CAGR of 5.92% during the forecast period from 2025 to 2032.
- The principal drivers are the growing instances of PAD and vascular disorders and their associated risk factors; increasing preference for minimally invasive endovascular procedures; technological advancements in product design, including drug-eluting technologies and bioresorbable scaffolds; and active product development activities among key market players.
- The leading Peripheral Vascular Devices Companies include Medtronic, Boston Scientific Corporation, B. Braun SE, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., AngioDynamics Inc., Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, and Conic Vascular, among others.

To know more about why North America is leading the market growth in the Peripheral Vascular Devices Market, Get a snapshot @ https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Peripheral Vascular Devices Overview

Peripheral vascular devices are a range of medical tools and implants used to diagnose and treat diseases of the peripheral vascular system, which includes all the blood vessels outside of the heart and brain. These devices are crucial for restoring proper blood flow and managing conditions like peripheral artery disease (PAD), where plaque buildup narrows arteries. According to DelveInsight's 2024 analysis, nearly 621 million people worldwide live with heart and circulatory diseases, reflecting a massive and growing patient pool in need of advanced vascular interventions. Peripheral artery disease alone affects around 6.5 million adults (5.8%) aged 40 years or older globally, while the burden of atrial fibrillation is expected to surpass 12.5 million patients by 2030.

Peripheral Vascular Devices Market Key Growth Drivers

- The rising prevalence of Peripheral Artery Disease (PAD) and other vascular disorders, driven by risk factors such as diabetes, obesity, hypertension, smoking, and an aging population, is significantly boosting demand for stents, angioplasty balloons, and atherectomy devices to restore blood flow and reduce complications.
- The growing preference for minimally invasive procedures is accelerating adoption, as these techniques offer shorter recovery times, reduced hospital stays, lower risk of complications, and improved patient outcomes compared to traditional open surgeries.
- Technological advancements in product design, including bioresorbable materials, advanced coatings, and imaging-guided delivery systems, are enabling the development of next-generation stents, drug-eluting balloons, atherectomy systems, and EVAR devices with higher precision and improved safety.
- Regulatory milestones are expanding the treatment arsenal, exemplified by Abbott's Esprit BTK Everolimus-Eluting Resorbable Scaffold System receiving FDA approval in April 2024 and a CE Mark in August 2025 for below-the-knee PAD.
- The Centers for Disease Control and Prevention (CDC) estimates that approximately 900,000 people are affected annually by deep vein thrombosis (DVT) or pulmonary embolism (PE) in the United States, sustaining demand for stents, thrombectomy systems, angioplasty balloons, and EVAR devices.
- Active strategic and product development activity among key players, including Shockwave Medical's September 2024 U.S. launch of its E8 Peripheral IVL Catheter and March 2025 launch of the Shockwave Javelin Peripheral IVL Catheter, is expanding treatment capability for complex, heavily calcified lesions.
- The combination of a rapidly expanding patient pool, increasing adoption of minimally invasive interventions, continuous device innovation, and supportive healthcare policies is expected to drive sustained growth through 2032.

Get a sneak peek at the Peripheral Vascular Devices Market Dynamics @ https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Peripheral Vascular Devices Market Segment Analysis

The Peripheral Vascular Devices Market by Product Type (Percutaneous Transluminal Angioplasty Balloon Catheters [Drug-Eluting Balloon Catheter, Cutting Balloon Catheter, and Scoring Balloon Catheter], Angioplasty Stents [Drug-Eluting Stents, Bare-Metal Stents, and Expandable Stents], Plaque Modification Devices [Atherectomy Devices and Thrombectomy Devices], Hemodynamic Flow Alteration Devices [Embolic Protection Devices and Chronic Total Occlusion Devices], Inferior Vena Cava Filters [Retrievable and Permanent], and Others), End-User (Hospitals, Specialty Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

By Product Type: The Angioplasty Stents category is estimated to account for the largest market share in 2024. Within this segment, Drug-Eluting Stents (DES) are projected to dominate, accounting for an estimated 22% market share, owing to superior clinical outcomes compared to bare-metal stents. DES release pharmacological agents such as paclitaxel or everolimus directly at the site of arterial narrowing, suppressing neointimal hyperplasia, reducing restenosis risk, and improving long-term vessel patency, supported by next-generation platforms featuring bioresorbable polymers and thinner struts.

By End-User: Hospitals are projected to remain the dominant end-users, accounting for nearly 68% share in 2024, owing to advanced healthcare infrastructure, well-equipped catheterization labs, specialized vascular surgery units, and the presence of highly skilled interventional cardiologists and vascular surgeons.

By Geography: North America is projected to dominate the market, holding approximately 41% of total share in 2024, driven by high PAD prevalence, advanced healthcare infrastructure, favorable reimbursement policies, and the presence of major players like Medtronic and Johnson & Johnson. Asia-Pacific is emerging as one of the fastest-growing markets, propelled by a large aging population, rising chronic disease risk factors, and expanding healthcare infrastructure investment across China and India.

Which MedTech key players in the Peripheral Vascular Devices Market are set to emerge as the trendsetter, explore @ https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Peripheral Vascular Devices Market Competitive Landscape

The Peripheral Vascular Devices market is highly competitive and moderately concentrated, with a handful of multinational corporations, including Medtronic, Abbott Laboratories, and Boston Scientific Corporation, holding a significant portion of total market share. These leaders leverage strong brand recognition, extensive product portfolios spanning stents, atherectomy devices, and catheters, and robust global distribution networks, while investing heavily in R&D to innovate with technologies like drug-eluting stents and intravascular lithotripsy. This intense competition drives continuous innovation and shapes pricing strategies, while posing a barrier to entry for smaller firms due to the high costs of R&D, clinical trials, and regulatory approvals.

Peripheral Vascular Devices Companies

Medtronic, Boston Scientific Corporation, B. Braun SE, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., AngioDynamics Inc., Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular, and others.

Peripheral Vascular Devices Market Restraints

Despite strong momentum, the Peripheral Vascular Devices market faces material constraints. The high cost of devices and procedures makes advanced treatments less accessible, especially in developing countries with limited healthcare budgets. This is compounded by a stringent and complex regulatory landscape that leads to lengthy, expensive approval processes and a risk of product recalls. Reimbursement challenges from insurers and government programs can make it financially unviable for facilities to adopt new, expensive technologies, while competition from alternative treatments such as pharmacological therapies and open surgeries remains a factor. A lack of specialized training and expertise among healthcare professionals in certain regions can further hinder widespread adoption of these sophisticated devices.

Interested in knowing the Peripheral Vascular Devices Market by 2032? Click to get a snapshot of the Peripheral Vascular Devices Market Trends-https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Scope of the Peripheral Vascular Devices Market Report

- Coverage- Global
- Study Period- 2022 to 2032
- Forecast Period- 2025-2032
- Peripheral Vascular Devices Companies- Medtronic, Boston Scientific Corporation, B. Braun SE, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, LeMaitre Vascular, Inc., W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., AngioDynamics Inc., Control Medical Technology, LLC, Walk Vascular, LLC, Transit Scientific, Conic Vascular, and others.
- Peripheral Vascular Devices Market Restraints and Regulatory Analysis
- Peripheral Vascular Devices Porter Five Forces Analysis and Market Assessment

Explore more information of the Peripheral Vascular Devices Market Insights @ https://www.delveinsight.com/sample-request/peripheral-vascular-devices-market?utm_source=openpr&utm_medium=pr&utm_campaign=kkpr

Table of Contents

1. Peripheral Vascular Devices Market Report Introduction
2. Peripheral Vascular Devices Market Executive Summary
3. Peripheral Vascular Devices Market Key Factors Analysis
4. Impact Analysis
5. Regulatory Analysis
6. Peripheral Vascular Devices Market Porter's Five Forces Analysis
7. Peripheral Vascular Devices Market Assessment
8. Competitive Landscape
9. Startup Funding & Investment Trends
10. Peripheral Vascular Devices Market Company and Product Profiles
11. KOL Views
12. Project Approach
13. About DelveInsight
14. Disclaimer & Contact Us

Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: info@delveinsight.com
Phone: 9650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

This release was published on openPR.